Full Coverage

Pharmacokinetics: Research on pharmacokinetics reported by scientists at GlaxoSmithKline

newsrx.com
Nov 2, 2009
 
Story Timeline:  25 days

"The objective of this study was to characterize the impact of casopitant, a novel neurokinin-1 receptor antagonist under investigation for the prevention of postoperative and chemotherapy-induced nausea and vomiting, on the... [read full story]                    

powered by
Add Comment
Latest article on this story:

Pharmacokinetics: Scientists at GlaxoSmithKline publish research in pharmacokinetics

 newsrx.com Nov 4, 2009
First article on this story:

Pharmacokinetics: Scientists at GlaxoSmithKline publish research in pharmacokinetics

 newsrx.com Nov 4, 2009
Selected publications with coverage of this story:
newsrx.com
RELATED
Found 1 documents:

Pharmacokinetics: Scientists at GlaxoSmithKline publish research in pharmacokinetics

newsrx.com
Nov 4, 2009
 

According to recent research from the United States, "Pharmacokinetic interactions between casopitant (a substrate and weak to moderate inhibitor of CYP3A), dexamethasone (a substrate and weak inducer of CYP3A), and ondansetron...

powered by